IBBQ holdings

All 256 positions of Invesco Nasdaq Biotechnology ETF.

Positions
256
Top 10 weight
46.1%
Effective holdings
29.1
1 / sum of squared weights
In stocks
94.9%
In bonds
0.0%
Outside the US
1.8%

Asset mix

  • Equity94.9%
  • Cash5.1%

Sectors

100% of stocks classified
  • Health Care90.6%
  • Technology4.3%
  • Materials0.0%

Countries

  • United States86.9%
  • Denmark0.9%
  • Canada0.3%
  • United Kingdom0.3%
  • Netherlands0.1%
  • Ireland0.1%
  • Israel0.0%
  • Switzerland0.0%
  • Taiwan0.0%

Holdings

#HoldingTypeWeightValueShares / parCountry
1GILDGilead Sciences IncEquity8.42%$9.1M61,948US
2AMGNAmgen IncEquity7.94%$8.6M21,107US
3VRTXVertex Pharmaceuticals IncEquity7.74%$8.4M16,661US
4MRNAModerna, Inc. Common StockEquity5.39%$5.8M29,630US
5REGNRegeneron Pharmaceuticals IncEquity5.12%$5.5M7,498US
6RVMDRevolution Medicines, Inc. Common StockEquity2.76%$3.0M15,898US
7ILMNIllumina IncEquity2.74%$3.0M11,210US
8BIIBBiogen Inc. Common StockEquity2.21%$2.4M10,967US
9ALNYAlnylam Pharmaceuticals, Inc.Equity2.06%$2.2M9,933US
10RPRXRoyalty Pharma plc Class A Ordinary SharesEquity1.72%$1.9M33,047
11ROIVRoivant Sciences Ltd. Common SharesEquity1.69%$1.8M53,587
12UTHRUnited Therapeutics CorpEquity1.57%$1.7M3,187US
13INCYIncyte Genomics IncEquity1.57%$1.7M15,048US
14ARGXargenx SE American Depositary SharesCash1.52%$1.7M2,016
15GHGuardant Health, Inc. Common StockEquity1.52%$1.6M9,958US
16INSMInsmed, Inc.Equity1.50%$1.6M16,202US
17VTRSViatris Inc. Common StockEquity1.37%$1.5M85,214US
18MEDPMedpace Holdings, Inc. Common StockEquity1.15%$1.2M2,059US
19EXELExelixis IncEquity1.00%$1.1M18,375US
20JAZZJazz Pharmaceuticals, Inc.Equity0.99%$1.1M4,817
21NBIXNeurocrine Biosciences IncEquity0.98%$1.1M7,535US
22SMMTSummit Therapeutics Inc. Common StockEquity0.94%$1.0M59,182US
23ASNDAscendis Pharma A/S Ordinary ShareEquity0.94%$1.0M4,562DK
24BBIOBridgeBio Pharma, Inc. Common StockEquity0.89%$967K14,863US
25ONCBeOne Medicines Ltd. American Depositary SharesCash0.86%$929K2,654
26HALOHalozyme Therapeutics, Inc.Equity0.85%$924K8,412US
27TEMTempus AI, Inc. Class A Common StockEquity0.83%$901K13,005US
28MDGLMadrigal Pharmaceuticals, Inc. Common StockEquity0.75%$814K1,706US
29BNTXBioNTech SE American Depositary ShareCash0.73%$792K8,603DE
30BMRNBioMarin Pharmaceuticals IncEquity0.73%$789K14,376US
31IBRXImmunityBio, Inc. Common StockEquity0.72%$778K78,542US
32TWSTTwist Bioscience Corporation Common StockEquity0.69%$747K4,913US
33KRYSKrystal Biotech, Inc. Common StockEquity0.67%$721K2,203US
34PCVXVaxcyte, Inc. Common StockEquity0.66%$717K11,025US
35TXG10x Genomics, Inc. Class A Common StockEquity0.64%$690K8,930US
36KYMRKymera Therapeutics, Inc. Common StockEquity0.62%$673K6,160US
37PTGXProtagonist Therapeutics, IncEquity0.62%$672K4,804US
38AXSMAxsome Therapeutics, IncEquity0.61%$660K3,882US
39SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)Cash0.59%$644K16,006FR
40CYTKCytokinetics Inc.Equity0.59%$639K10,311US
41ARWRArrowhead Research CorporationEquity0.59%$638K10,498US
42CAICaris Life Sciences, Inc. Common StockEquity0.53%$576K20,957US
43PRAXPraxis Precision Medicines, Inc. Common StockEquity0.50%$543K2,059US
44IONSIonis Pharmaceuticals, Inc. Common StockEquity0.49%$533K12,314US
45SYRESpyre Therapeutics, Inc. Common StockEquity0.48%$521K6,526US
46AMRXAmneal Pharmaceuticals, Inc. Class A Common StockEquity0.47%$507K25,824US
47ALKSAlkermes Inc. plcEquity0.46%$500K12,457
48IMVTImmunovant, Inc. Common StockEquity0.43%$464K15,339US
49RYTMRhythm Pharmaceuticals, Inc. Common StockEquity0.42%$458K5,113US
50IOVAIovance Biotherapeutics, Inc. Common StockEquity0.41%$447K33,583US
51LGNDLigand Pharmaceuticals Inc.Equity0.41%$442K1,497US
52GRALGRAIL, Inc. Common StockEquity0.40%$438K3,300US
53KODKodiak Sciences Inc Common StockEquity0.40%$437K4,633US
54CGONCG Oncology, Inc. Common stockEquity0.38%$415K6,556US
55ERASErasca, Inc. Common StockEquity0.37%$401K25,962US
56MIRMMirum Pharmaceuticals, Inc. Common StockEquity0.36%$392K4,818US
57COGTCogent Biosciences, Inc. Common StockEquity0.36%$387K12,872US
58PTCTPTC Therapeutics, Inc.Equity0.36%$386K6,176US
59SRRKScholar Rock Holding Corporation Common StockEquity0.35%$381K9,031US
60ORKAOruka Therapeutics, Inc. Common StockEquity0.35%$379K4,900US
61ABVXAbivax SA American Depositary SharesCash0.35%$377K4,233FR
62TVTXTravere Therapeutics, Inc. Common StockEquity0.34%$364K7,004US
63CRSPCRISPR Therapeutics AGEquity0.33%$361K7,160US
64DFTXDefinium Therapeutics, Inc. Common SharesEquity0.31%$341K9,969
65EWTXEdgewise Therapeutics, Inc. Common StockEquity0.29%$316K8,047US
66INDVIndivior Pharmaceuticals, Inc. Common StockEquity0.29%$310K8,745US
67ADPTAdaptive Biotechnologies Corporation Common StockEquity0.29%$309K11,848US
68ABCLAbCellera Biologics Inc. Common SharesEquity0.27%$289K24,051CA
69RLAYRelay Therapeutics, Inc. Common StockEquity0.26%$283K16,233US
70TNGXTango Therapeutics, Inc.Equity0.26%$282K12,513US
71KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary SharesEquity0.26%$282K3,576GB
72VCYTVeracyte, Inc.Equity0.24%$261K5,988US
73XENEXenon Pharmaceuticals IncEquity0.24%$259K7,169
74GMABGenmab A/S ADSCash0.24%$259K7,177DK
75IDYAIDEAYA Biosciences, Inc. Common StockEquity0.24%$258K7,147US
76AMLXAmylyx Pharmaceuticals, Inc. Common StockEquity0.23%$253K9,314US
77ACADAcadia Pharmaceuticals Inc.Equity0.23%$250K12,781US
78TARSTarsus Pharmaceuticals, Inc. Common StockEquity0.23%$248K3,429US
79ARQTArcutis Biotherapeutics, Inc. Common StockEquity0.21%$228K9,314US
80DYNDyne Therapeutics, Inc. Common StockEquity0.21%$227K13,851US
81DNLIDenali Therapeutics Inc. Common StockEquity0.20%$222K11,877US
82ELVNEnliven Therapeutics, Inc. Common StockEquity0.20%$221K5,440US
83PGENPrecigen, Inc. Common StockEquity0.19%$201K26,495US
84MBXMBX Biosciences, Inc. Common StockEquity0.17%$189K3,557US
85NAMSNewAmsterdam Pharma Company N.V. Ordinary SharesEquity0.17%$189K8,887
86BEAMBeam Therapeutics Inc. Common StockEquity0.17%$188K7,659US
87SUPNSupernus Pharmaceuticals, Inc.Equity0.17%$181K4,294US
88IRONDisc Medicine, Inc. Common StockEquity0.16%$174K2,863US
89ADMAADMA Biologics, Inc.Equity0.16%$172K16,632US
90HRMYHarmony Biosciences Holdings, Inc. Common StockEquity0.16%$171K4,315US
91NRIXNurix Therapeutics, Inc. Common stockEquity0.16%$171K7,693US
92PHVSPharvaris N.V. Ordinary SharesEquity0.15%$162K5,213NL
93AUPHAurinia Pharmaceuticals IncEquity0.15%$160K9,884
94VERAVera Therapeutics, Inc. Class A Common StockEquity0.15%$159K5,363US
95BCRXBioCryst Pharmaceuticals IncEquity0.15%$158K19,004US
96RXRXRecursion Pharmaceuticals, Inc. Class A Common StockEquity0.14%$157K39,694US
97GPCRStructure Therapeutics Inc. American Depositary SharesCash0.14%$156K6,085
98VCELVericel CorporationEquity0.14%$152K3,800US
99MLYSMineralys Therapeutics, Inc. Common StockEquity0.14%$146K6,541US
100FTREFortrea Holdings Inc. Common StockEquity0.13%$144K7,076US
101SRPTSarepta Therapeutics,, Inc. Common StockEquity0.13%$142K7,820US
102ALVOAlvotech Ordinary SharesEquity0.13%$142K25,091
103AGIOAgios Pharmaceuticals, Inc.Equity0.13%$141K4,429US
104VIRVir Biotechnology, Inc. Common StockEquity0.13%$140K12,604US
105XERSXeris Biopharma Holdings, Inc. Common StockEquity0.13%$138K13,523US
106TRVITrevi Therapeutics, Inc. Common StockEquity0.12%$135K10,553US
107NVAXNovavax IncEquity0.12%$135K12,288US
108XNCRXencor, Inc.Equity0.12%$135K5,492US
109URGNUroGen Pharma Ltd. Ordinary SharesEquity0.12%$134K3,627US
110ZYMEZymeworks Inc.Equity0.12%$133K5,248US
111NTLAIntellia Therapeutics, IncEquity0.12%$131K10,427US
112SEPNSepterna, Inc. Common StockEquity0.12%$128K3,473US
113LEGNLegend Biotech Corporation American Depositary SharesCash0.12%$128K6,822
114PSNLPersonalis, Inc. Common StockEquity0.12%$128K7,939US
115ZBIOZenas BioPharma, Inc. Common StockEquity0.12%$127K4,834US
116NVCRNovoCure Limited Ordinary SharesEquity0.11%$123K8,667
117OCULOcular Therapeutix, Inc.Equity0.11%$122K16,236US
118ANIPANI Pharmaceuticals, Inc.Equity0.11%$121K1,686US
119ETONEton Pharmaceutcials, Inc. Common StockEquity0.11%$117K2,138US
120QUREuniQure N.V.Equity0.11%$116K5,146
121STOKStoke Therapeutics, Inc. Common StockEquity0.11%$115K4,792US
122CMPSCOMPASS Pathways Plc American Depository SharesCash0.11%$114K9,958GB
123ABSIAbsci Corporation Common StockEquity0.11%$114K12,750US
124SNDXSyndax Pharmaceuticals, Inc.Equity0.10%$112K6,644US
125INVAInnoviva, Inc. Common StockEquity0.10%$112K5,374US
126RAREUltragenyx Pharmaceutical Inc.Equity0.10%$112K7,301US
127PCRXPacira BioSciences, Inc. Common StockEquity0.10%$107K2,944US
128TSHATaysha Gene Therapies, Inc. Common StockEquity0.10%$107K24,166US
129MAZEMaze Therapeutics, Inc. Common StockEquity0.10%$106K4,113US
130RAPPRapport Therapeutics, Inc. Common StockEquity0.10%$106K3,547US
131GHRSGH Research PLC Ordinary SharesEquity0.10%$104K5,099IE
132OMEROmeros CorporationEquity0.10%$103K5,385US
133ANABAnaptysBio, Inc. Common StockEquity0.09%$102K2,208US
134IMCRImmunocore Holdings plc American Depositary SharesCash0.09%$100K3,451GB
135INBXInhibrx Biosciences, Inc. Common StockEquity0.09%$100K1,081US
136ORICOric Pharmaceuticals, Inc. Common StockEquity0.09%$92K7,675US
137REPLReplimune Group, Inc.Equity0.08%$91K7,002US
138TYRATyra Biosciences, Inc. Common StockEquity0.08%$88K4,424US
139HROWHarrow, Inc. Common StockEquity0.08%$85K2,797US
140BCAXBicara Therapeutics Inc. Common StockEquity0.08%$85K4,901US
141TRAXFirst Tracks Biotherapeutics, Inc. Ordinary SharesEquity0.08%$85K2,640US
142JANXJanux Therapeutics, Inc. Common StockEquity0.08%$84K4,560US
143VORVor Biopharma Inc. Common StockEquity0.08%$84K4,405US
144ZLABZai Lab Limited American Depositary SharesCash0.08%$82K3,294
145AMPHAmphastar Pharmaceuticals, Inc.Equity0.08%$82K3,164US
146MNKDMannkind CorporationEquity0.08%$82K23,847US
147MRVIMaravai LifeSciences Holdings, Inc. Class A Common StockEquity0.07%$80K11,056US
148CSTLCastle Biosciences, Inc. Common StockEquity0.07%$77K2,277US
149MGTXMeiraGTx Holdings plc Ordinary SharesEquity0.07%$75K7,118US
150SVRASavara Inc.Equity0.07%$74K15,381US
151CGEMCullinan Therapeutics, Inc. Common StockEquity0.07%$74K4,781US
152KURAKura Oncology, Inc.Equity0.06%$70K6,655US
153ALMSAlumis Inc. Common StockEquity0.06%$67K9,609US
154GRFSGrifois, S.A.Cash0.06%$67K9,011ES
155RIGLRigel Pharmaceuticals Inc. (New)Equity0.06%$67K1,369US
156GLUEMonte Rosa Therapeutics, Inc. Common StockEquity0.06%$65K6,334US
157CRVSCorvus Pharmaceuticals, Inc.Equity0.06%$64K6,310US
158SANASana Biotechnology, Inc. Common StockEquity0.06%$62K22,207US
159ABUSArbutus Biopharma Corporation Common StockEquity0.06%$62K14,814
160AVBPArriVent BioPharma, Inc. Common StockEquity0.06%$61K3,642US
161ARDXArdelyx, Inc.Equity0.06%$61K18,607US
162PAHCPhibro Animal Health Corporation Class AEquity0.05%$59K1,572US
163GERNGeron CorpEquity0.05%$58K47,306US
164ANNXAnnexon, Inc. Common StockEquity0.05%$56K14,076US
165CADLCandel Therapeutics, Inc. Common StockEquity0.05%$55K5,692US
166SLDBSolid Biosciences Inc. Common StockEquity0.05%$54K7,967US
167COLLCollegium Pharmaceutical, Inc. Common StockEquity0.05%$54K2,446US
168DSGNDesign Therapeutics, Inc. Common StockEquity0.05%$54K4,698US
169MESOMesoblast Limited American Depositary SharesCash0.05%$54K3,924AU
170PACBPacific Biosciences of California, Inc.Equity0.05%$53K23,073US
171FDMT4D Molecular Therapeutics, Inc. Common StockEquity0.05%$51K4,049US
172OABIOmniAb, Inc. Common StockEquity0.05%$51K10,855US
173OLMAOlema Pharmaceuticals, Inc. Common StockEquity0.05%$50K6,445US
174WVEWave Life Sciences Ltd. Ordinary SharesEquity0.05%$50K14,463
175AURAAura Biosciences, Inc. Common StockEquity0.05%$50K7,697US
176ZVRAZevra Therapeutics, Inc. Common StockEquity0.04%$49K4,419US
177PRMEPrime Medicine, Inc. Common StockEquity0.04%$48K13,463US
178IRWDIronwood Pharmaceuticals, Inc. - Class AEquity0.04%$47K12,254US
179AGPXXInvesco Government & Agency PortfolioCash0.04%$47K47,299
180AQSTAquestive Therapeutics, Inc. Common StockEquity0.04%$45K9,415US
181PHATPhathom Pharmaceuticals, Inc. Common StockEquity0.04%$43K6,027US
182CRMDCorMedix Inc.Equity0.04%$42K5,783US
183ACRSAclaris Therapeutics, Inc.Equity0.04%$41K10,922US
184SGMTSagimet Biosciences Inc. Series A Common StockEquity0.04%$41K4,582US
185NGNENeurogene, Inc. Common StockEquity0.04%$40K1,501US
186CTMXCytomX Therapeutics, Inc.Equity0.04%$40K16,015US
187RGNXREGENXBIO Inc.Equity0.04%$40K4,887US
188EOLSEvolus, Inc. Common StockEquity0.04%$38K4,935US
189PBYIPUMA BIOTECHNOLOGY INCEquity0.04%$38K3,820US
190ALTAltimmune, Inc. Common StockEquity0.03%$38K14,437US
191ARVNArvinas, IncEquity0.03%$37K4,862US
192ALLOAllogene Therapeutics, Inc. Common StockEquity0.03%$36K25,645US
193KMDAKamada LtdEquity0.03%$34K4,375IL
194LKFTLakefront Biotherapeutics American Depositary SharesCash0.03%$34K1,150BE
195SLNSilence Therapeutics Plc American Depository ShareCash0.03%$34K3,538GB
196SPRYARS Pharmaceuticals, Inc. Common StockEquity0.03%$34K7,380US
197TKNOAlpha Teknova, Inc. Common StockEquity0.03%$33K3,966US
198EDITEditas Medicine, Inc. Common StockEquity0.03%$33K11,616US
199PRTAProthena Corporation plc Ordinary SharesEquity0.03%$33K3,816
200CTNMContineum Therapeutics, Inc. Class A Common StockEquity0.03%$32K2,464US
201TECXTectonic Therapeutic, Inc. Common StockEquity0.03%$32K1,399US
202AVIRAtea Pharmaceuticals, Inc. Common StockEquity0.03%$31K6,057US
203KYTXKyverna Therapeutics, Inc. Common StockEquity0.03%$28K4,589US
204ARCTArcturus Therapeutics Holdings Inc. Common StockEquity0.03%$28K2,144US
205AUTLAutolus Therapeutics plc American Depositary ShareCash0.02%$26K14,870GB
206ENTAEnanta Pharmaceuticals, IncEquity0.02%$26K2,173US
207CCCCC4 Therapeutics, Inc.Equity0.02%$26K9,110US
208OBIOOrchestra BioMed Holdings, Inc. Ordinary SharesEquity0.02%$26K4,465US
209CABACabaletta Bio, Inc. Common StockEquity0.02%$24K12,268US
210EYPTEyePoint, Inc. Common StockEquity0.02%$22K6,252US
211BIOABioAge Labs, Inc. Common StockEquity0.02%$22K3,477US
212RCKTRocket Pharmaceuticals, Inc. Common StockEquity0.02%$21K8,130US
213FULCFulcrum Therapeutics, Inc. Common StockEquity0.02%$21K5,678US
214LRMRLarimar Therapeutics, Inc. Common StockEquity0.02%$21K7,708US
215VNDAVanda Pharmaceuticals Inc.Equity0.02%$20K4,488US
216LXEOLexeo Therapeutics, Inc. Common StockEquity0.02%$19K5,996US
217ACIUAC Immune SAEquity0.02%$19K7,529CH
218UPBUpstream Bio, Inc. Common StockEquity0.02%$19K4,079US
219IMRXImmuneering Corporation Class A Common StockEquity0.02%$18K4,803US
220LFCRLifecore Biomedical, Inc. Common StockEquity0.02%$18K2,790US
221QSIQuantum-Si Incorporated Class A Common StockEquity0.02%$18K14,482US
222SIGASIGA Technologies Inc.Equity0.02%$18K5,349US
223KROSKeros Therapeutics, Inc. Common StockEquity0.02%$17K1,499US
224SIONSionna Therapeutics, Inc. Common StockEquity0.02%$16K3,335US
225TRDAEntrada Therapeutics, Inc. Common StockEquity0.01%$16K2,889US
226LYELLyell Immunopharma, Inc. Common StockEquity0.01%$15K1,749US
227IVVDInvivyd, Inc. Common StockEquity0.01%$15K21,868US
228BCYCBicycle Therapeutics plc American Depositary SharesCash0.01%$13K3,451GB
229PYXSPyxis Oncology, Inc. Common StockEquity0.01%$12K6,177US
230CHRSCoherus Oncology, Inc. Common StockEquity0.01%$12K11,478US
231PEPGPepGen Inc. Common StockEquity0.01%$12K5,139US
232MENSJyong Biotech Ltd. Ordinary SharesEquity0.01%$12K5,537TW
233NBPNovaBridge Biosciences American Depositary SharesCash0.01%$11K8,262
234CDXSCodexis, Inc.Equity0.01%$11K8,113US
235AVXLAnavex Life SciencesEquity0.01%$11K6,860US
236VYGRVoyager Therapeutics, Inc. Common StockEquity0.01%$11K4,448US
237USDProShares Ultra SemiconductorsCash0.01%$9K9,230US
238HUMAHumacyte, Inc. Common StockEquity0.01%$9K20,606US
239FHTXFoghorn Therapeutics Inc. Common StockEquity0.01%$9K4,419US
240TNYATenaya Therapeutics, Inc. Common StockEquity0.01%$9K15,851US
241LENZLENZ Therapeutics, Inc. Common StockEquity0.01%$8K2,282US
242BDTXBlack Diamond Therapeutics, Inc. Common StockEquity0.01%$8K4,191US
243AARDAardvark Therapeutics, Inc. Common StockEquity0.01%$8K1,600US
244RANIRani Therapeutics Holdings, Inc. Class A Common StockEquity0.01%$7K8,269
245NMRANeumora Therapeutics, Inc. Common StockEquity0.01%$6K13,308US
246GOSSGossamer Bio, Inc. Common StockEquity0.00%$4K435US
247CRBUCaribou Biosciences, Inc. Common StockEquity0.00%$4K7,303US
248Cartesian Therapeutics IncOther0.00%$3592,633US
249Coherus Oncology Inc2050-12Other0.00%$010,938US
250Eli Lilly & CoOther0.00%$06,344
251Esperion Therapeutics IncOther0.00%$013,225US
252Novo Nordisk A/SOther0.00%$03,794DK
253OmniAb Inc2027-11Other0.00%$0125US
254OmniAb Inc2027-11Other0.00%$0125US
255SECURITIES LENDING - BNYMCash0.00%$01
256THRDThird Harmonic Bio, Inc. Common StockEquity0.00%$01,605US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

ActionHoldingWeight beforeWeight afterShares vs flowsBetween reports
DecreaseGILDGilead Sciences, Inc.9.61%7.39%−20.4%Feb 28, 2026 → May 31, 2026 SEC
DecreaseAMGNAmgen Inc.9.12%7.10%−16.1%Feb 28, 2026 → May 31, 2026 SEC
DecreaseVRTXVertex Pharmaceuticals Inc.9.30%7.38%−17.7%Feb 28, 2026 → May 31, 2026 SEC
ExitACLXArcellx, Inc.0.49%——Feb 28, 2026 → May 31, 2026 SEC
ExitFOLDAmicus Therapeutics, Inc.0.33%——Feb 28, 2026 → May 31, 2026 SEC
ExitTERNTerns Pharmaceuticals, Inc.0.28%——Feb 28, 2026 → May 31, 2026 SEC
ExitAPLSApellis Pharmaceuticals, Inc.0.20%——Feb 28, 2026 → May 31, 2026 SEC
IncreaseCNTACentessa Pharmaceuticals PLC0.19%0.38%+24.4%Feb 28, 2026 → May 31, 2026 SEC
IncreaseIMVTImmunovant, Inc.0.36%0.54%+16.8%Feb 28, 2026 → May 31, 2026 SEC
IncreasePRAXPraxis Precision Medicines, Inc.0.63%0.78%+10.4%Feb 28, 2026 → May 31, 2026 SEC
IncreaseMIRMMirum Pharmaceuticals, Inc.0.36%0.49%+16.3%Feb 28, 2026 → May 31, 2026 SEC
ExitRAPTRAPT Therapeutics, Inc.0.12%——Feb 28, 2026 → May 31, 2026 SEC
IncreaseDYNDyne Therapeutics, Inc.0.16%0.25%+16.4%Feb 28, 2026 → May 31, 2026 SEC
ExitDAWNDay One Biopharmaceuticals, Inc.0.08%——Feb 28, 2026 → May 31, 2026 SEC
IncreaseKODKodiak Sciences Inc.0.10%0.18%+16.5%Feb 28, 2026 → May 31, 2026 SEC
IncreaseWVEWave Life Sciences Ltd.0.17%0.10%+13.4%Feb 28, 2026 → May 31, 2026 SEC
ExitVTYXVentyx Biosciences, Inc.0.07%——Feb 28, 2026 → May 31, 2026 SEC
IncreaseGPCRStructure Therapeutics Inc.0.31%0.24%+17.4%Feb 28, 2026 → May 31, 2026 SEC
IncreaseBCRXBioCryst Pharmaceuticals, Inc.0.14%0.18%+20.1%Feb 28, 2026 → May 31, 2026 SEC
IncreaseBCAXBicara Therapeutics Inc.0.07%0.11%+15.6%Feb 28, 2026 → May 31, 2026 SEC
IncreaseKYMRKymera Therapeutics, Inc.0.49%0.53%+13.1%Feb 28, 2026 → May 31, 2026 SEC
IncreaseBNTXBioNTech SE0.83%0.87%+12.1%Feb 28, 2026 → May 31, 2026 SEC
New positionTRAXFirst Tracks Biotherapeutics, Inc.—0.03%—Feb 28, 2026 → May 31, 2026 SEC
IncreasePSNLPersonalis, Inc.0.06%0.09%+17.0%Feb 28, 2026 → May 31, 2026 SEC
IncreaseGLUEMonte Rosa Therapeutics, Inc.0.09%0.12%+17.3%Feb 28, 2026 → May 31, 2026 SEC
IncreaseERASErasca, Inc.0.29%0.32%+10.1%Feb 28, 2026 → May 31, 2026 SEC
IncreaseVORVor BioPharma Inc.0.02%0.05%+145.4%Feb 28, 2026 → May 31, 2026 SEC
IncreaseCADLCandel Therapeutics, Inc.0.02%0.05%+31.9%Feb 28, 2026 → May 31, 2026 SEC
IncreaseVIRVir Biotechnology, Inc.0.09%0.12%+13.0%Feb 28, 2026 → May 31, 2026 SEC
IncreaseACRSAclaris Therapeutics, Inc.0.02%0.04%+10.6%Feb 28, 2026 → May 31, 2026 SEC
IncreaseCRVSCorvus Pharmaceuticals, Inc.0.10%0.08%+11.3%Feb 28, 2026 → May 31, 2026 SEC
IncreaseKYTXKyverna Therapeutics, Inc.0.03%0.04%+30.5%Feb 28, 2026 → May 31, 2026 SEC
IncreaseVERAVera Therapeutics, Inc.0.19%0.20%+12.1%Feb 28, 2026 → May 31, 2026 SEC
IncreaseGMABGenmab A/S0.13%0.13%+11.1%Feb 28, 2026 → May 31, 2026 SEC
DecreaseZLABZai Lab Ltd.0.06%0.05%−12.6%Feb 28, 2026 → May 31, 2026 SEC
IncreaseCTNMContineum Therapeutics, Inc.0.03%0.03%+30.6%Feb 28, 2026 → May 31, 2026 SEC
IncreasePHATPhathom Pharmaceuticals, Inc.0.07%0.06%+12.4%Feb 28, 2026 → May 31, 2026 SEC
IncreaseALMSAlumis Inc.0.21%0.22%+30.8%Feb 28, 2026 → May 31, 2026 SEC
IncreaseLRMRLarimar Therapeutics, Inc.0.03%0.03%+26.3%Feb 28, 2026 → May 31, 2026 SEC
IncreaseALTAltimmune, Inc.0.03%0.03%+19.4%Feb 28, 2026 → May 31, 2026 SEC
IncreaseFULCFulcrum Therapeutics, Inc.0.03%0.04%+20.9%Feb 28, 2026 → May 31, 2026 SEC
DecreaseFDMT4D Molecular Therapeutics, Inc.0.04%0.04%−11.3%Feb 28, 2026 → May 31, 2026 SEC
IncreaseBIOABioAge Labs, Inc.0.06%0.06%+19.4%Feb 28, 2026 → May 31, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.